SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-416117
Filing Date
2013-10-29
Accepted
2013-10-29 17:00:59
Documents
3
Period of Report
2013-10-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d619144d8k.htm 8-K 14356
2 EX-99.1 d619144dex991.htm EX-99.1 7102
3 GRAPHIC g619144img002.jpg GRAPHIC 11089
  Complete submission text file 0001193125-13-416117.txt   38184
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 131177010
SIC: 2835 In Vitro & In Vivo Diagnostic Substances